trending Market Intelligence /marketintelligence/en/news-insights/trending/403jb6ihzvlfk35pr1lqta2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Synthetic Biologics appoints interim CEO to permanent role

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Synthetic Biologics appoints interim CEO to permanent role

Synthetic Biologics Inc. said it named Steven Shallcross CEO.

Shallcross, who had been serving as interim CEO, will also continue as the company's CFO. He was also appointed as a director of the company.

Rockville, Md.-based Synthetic Biologics develops therapeutics designed to preserve the human microbiome.